Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELUW) Research & Development (2020 - 2025)

Historic Research & Development for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $4.6 million.

  • Celularity's Research & Development rose 1744.57% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year increase of 1670.93%. This contributed to the annual value of $17.4 million for FY2024, which is 4293.12% down from last year.
  • Celularity's Research & Development amounted to $4.6 million in Q3 2025, which was up 1744.57% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Celularity's Research & Development peaked at $25.3 million during Q2 2022, and registered a low of -$272000.0 during Q4 2023.
  • Its 5-year average for Research & Development is $11.9 million, with a median of $8.6 million in 2023.
  • In the last 5 years, Celularity's Research & Development crashed by 10247.5% in 2023 and then skyrocketed by 150735.29% in 2024.
  • Celularity's Research & Development (Quarter) stood at $24.7 million in 2021, then crashed by 55.48% to $11.0 million in 2022, then crashed by 102.47% to -$272000.0 in 2023, then soared by 1507.35% to $3.8 million in 2024, then increased by 20.11% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, $3.4 million for Q2 2025, and $3.7 million during Q1 2025.